MW6473A1 - Cephalosporin ethers - Google Patents

Cephalosporin ethers

Info

Publication number
MW6473A1
MW6473A1 MW64/73*UA MW6473A MW6473A1 MW 6473 A1 MW6473 A1 MW 6473A1 MW 6473 A MW6473 A MW 6473A MW 6473 A1 MW6473 A1 MW 6473A1
Authority
MW
MALAWI
Prior art keywords
cephalosporin
ethers
cephalosporin ethers
Prior art date
Application number
MW64/73*UA
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23201377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MW6473(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MW6473A1 publication Critical patent/MW6473A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
MW64/73*UA 1972-11-28 1973-11-21 Cephalosporin ethers MW6473A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US310191A US3917587A (en) 1972-11-28 1972-11-28 Cephalosporin ethers

Publications (1)

Publication Number Publication Date
MW6473A1 true MW6473A1 (en) 1974-09-11

Family

ID=23201377

Family Applications (1)

Application Number Title Priority Date Filing Date
MW64/73*UA MW6473A1 (en) 1972-11-28 1973-11-21 Cephalosporin ethers

Country Status (27)

Country Link
US (1) US3917587A (US06174465-20010116-C00003.png)
JP (2) JPS49133394A (US06174465-20010116-C00003.png)
AR (3) AR204984A1 (US06174465-20010116-C00003.png)
AT (2) ATA993473A (US06174465-20010116-C00003.png)
BE (1) BE807780A (US06174465-20010116-C00003.png)
BG (2) BG21414A3 (US06174465-20010116-C00003.png)
BR (2) BR7309298D0 (US06174465-20010116-C00003.png)
CH (2) CH588495A5 (US06174465-20010116-C00003.png)
CS (2) CS183722B2 (US06174465-20010116-C00003.png)
DD (2) DD110663A5 (US06174465-20010116-C00003.png)
DE (1) DE2359353A1 (US06174465-20010116-C00003.png)
EG (2) EG11046A (US06174465-20010116-C00003.png)
ES (2) ES420870A1 (US06174465-20010116-C00003.png)
FR (1) FR2207697B1 (US06174465-20010116-C00003.png)
GB (1) GB1456221A (US06174465-20010116-C00003.png)
HU (2) HU166847B (US06174465-20010116-C00003.png)
IE (1) IE39476B1 (US06174465-20010116-C00003.png)
IL (1) IL43661A (US06174465-20010116-C00003.png)
MW (1) MW6473A1 (US06174465-20010116-C00003.png)
NL (2) NL7316178A (US06174465-20010116-C00003.png)
OA (2) OA04512A (US06174465-20010116-C00003.png)
PH (1) PH14698A (US06174465-20010116-C00003.png)
PL (2) PL94245B1 (US06174465-20010116-C00003.png)
RO (3) RO63081A (US06174465-20010116-C00003.png)
SU (1) SU1149879A3 (US06174465-20010116-C00003.png)
YU (2) YU36527B (US06174465-20010116-C00003.png)
ZA (1) ZA738993B (US06174465-20010116-C00003.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
SE428022B (sv) * 1972-06-29 1983-05-30 Ciba Geigy Ag 7beta-amino-cefam-3-on-4-karboxylsyraforeningar till anvendning for framstellning av cefalosporinderivat
US4060688A (en) * 1972-11-28 1977-11-29 Eli Lilly And Company Cephalosporin intermediates
US4053469A (en) * 1973-02-28 1977-10-11 Shionogi & Co., Ltd. Intermediates for the preparation of 7-acylamino-3-oxyiminomethyl-3-cephem-4-carboxylic acids
CH605997A5 (US06174465-20010116-C00003.png) * 1974-08-30 1978-10-13 Ciba Geigy Ag
GB1485488A (en) * 1974-10-03 1977-09-14 Farmaceutici Italia Preparation of cephalosporins
US3985746A (en) * 1975-03-25 1976-10-12 E. R. Squibb & Sons, Inc. 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
CH622802A5 (US06174465-20010116-C00003.png) * 1975-08-20 1981-04-30 Ciba Geigy Ag
US4031084A (en) * 1975-10-23 1977-06-21 Eli Lilly And Company Process for cephalosporin antibiotic intermediates
US5350845A (en) * 1992-04-08 1994-09-27 Eli Lilly And Company Process for preparing 7-substituted-amino-3-hydroxy-3-cephem-4-protected carboxy-sulfoxide esters
IN181695B (US06174465-20010116-C00003.png) * 1992-08-10 1998-09-05 Ranbaxy Lab Ltd
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
IN184516B (US06174465-20010116-C00003.png) * 1996-01-19 2000-09-02 Lupin Laoratories Ltd
CN112321611B (zh) * 2020-10-29 2022-05-06 湖北凌晟药业有限公司 一种头孢沙定母核的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241656A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
GB1277415A (en) * 1968-06-14 1972-06-14 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives

Also Published As

Publication number Publication date
NL7316177A (US06174465-20010116-C00003.png) 1974-05-30
BG21414A3 (bg) 1976-05-20
NL7316178A (US06174465-20010116-C00003.png) 1974-05-30
RO63112A (fr) 1978-08-15
SU1149879A3 (ru) 1985-04-07
PH14698A (en) 1981-11-10
DD110280A5 (US06174465-20010116-C00003.png) 1974-12-12
CS183722B2 (en) 1978-07-31
BR7309297D0 (pt) 1974-09-24
YU310473A (en) 1982-02-25
DD110663A5 (US06174465-20010116-C00003.png) 1975-01-05
FR2207697B1 (US06174465-20010116-C00003.png) 1977-04-22
YU36526B (en) 1984-02-29
JPS4982693A (US06174465-20010116-C00003.png) 1974-08-08
HU166396B (US06174465-20010116-C00003.png) 1975-03-28
EG11175A (en) 1977-01-31
IL43661A0 (en) 1974-03-14
IE39476B1 (en) 1978-10-25
CH599222A5 (US06174465-20010116-C00003.png) 1978-05-12
AR221315A1 (es) 1981-01-30
US3917587A (en) 1975-11-04
CS183723B2 (en) 1978-07-31
DE2359353A1 (de) 1974-05-30
AU6276373A (en) 1975-05-22
PL94828B1 (pl) 1977-08-31
IE39476L (en) 1974-05-28
JPS49133394A (US06174465-20010116-C00003.png) 1974-12-21
BR7309298D0 (pt) 1974-09-24
CH588495A5 (US06174465-20010116-C00003.png) 1977-06-15
ATA993473A (de) 1976-09-15
AR204984A1 (es) 1976-03-31
BE807780A (fr) 1974-05-27
OA04512A (fr) 1980-03-30
RO63081A (fr) 1978-07-15
EG11046A (en) 1976-11-30
FR2207697A1 (US06174465-20010116-C00003.png) 1974-06-21
PL94245B1 (US06174465-20010116-C00003.png) 1977-07-30
ZA738993B (en) 1975-06-25
AR217389A1 (es) 1980-03-31
HU166847B (US06174465-20010116-C00003.png) 1975-06-28
RO63739A2 (fr) 1979-01-15
BG21861A3 (bg) 1976-09-20
IL43661A (en) 1982-11-30
OA04511A (fr) 1980-03-30
YU310573A (en) 1982-02-25
ES420870A1 (es) 1976-04-01
YU36527B (en) 1984-02-29
ES420868A1 (es) 1976-04-01
GB1456221A (en) 1976-11-24
ATA993573A (de) 1976-09-15

Similar Documents

Publication Publication Date Title
ZA731723B (en) Herbicidal ethers
KE2734A (en) Herbicidal ethers
ZA732980B (en) Substituted sulfonylacetamido cephalosporins
ZA738993B (en) Cephalosporin ethers
IE37402L (en) Cephalosporin derivatives
MW6573A1 (en) Alpha-aminoacyl cephalosporin ethers
AU4856272A (en) Cephalosporins
CA1012533A (en) Ethers
AU4856472A (en) Cephalosporins
ZA732592B (en) Oxime ethers
ZA732916B (en) Antibiotics
CA996553A (en) Ethers
AU5310473A (en) Cephalosporin compounds
ZA731618B (en) Cephalosporin derivatives
ZA733567B (en) Isocyanodiphenyl ethers
ZA731805B (en) New ethers
YU167572A (en) Lamelna sklopka z zunanjimi lamelami
AU4856372A (en) Cephalosporins
ZA748050B (en) Cephalosporin derivatives
ZA732576B (en) Cephalosporin synthesis
IL41986A0 (en) Cephalosporin synthesis
AU478052B2 (en) Cephalosporin ethers
AU6166273A (en) Antibiotics
ZA73892B (en) New ethers
AU4956072A (en) Weatherboards